Want to see DE:93M1 full AI Analyst Report?
Top Page
MPH Health Care AG
(XETRA:93M1)
Select Model
Select Model
Rating:74Outperform
Price Target:
€29.00
▲(15.54% Upside)
Action:Reiterated
Date:09/06/26
The score is driven primarily by solid valuation (low P/E and very high dividend yield) and supportive technical strength (price above key moving averages with positive momentum). These positives are offset by the main fundamental risk: uneven cash-flow generation and highly volatile revenues despite improved profitability and a strong, low-debt balance sheet.
Positive Factors
Conservative balance sheet
Very low debt relative to equity gives MPH substantial financial flexibility and limits the burden of interest or refinancing. This conservative funding structure can help the company withstand volatility in portfolio results while preserving capacity to manage and develop healthcare holdings.
Negative Factors
Volatile cash generation
Inconsistent operating and free cash flow weakens confidence that reported earnings can reliably convert into internally generated funds. Repeated negative periods and the sharp 2025 decline may constrain self-funding, distributions, and the ability to develop portfolio investments without relying on asset realizations.
Read all positive and negative factors
Positive Factors
Negative Factors
Conservative balance sheet
Very low debt relative to equity gives MPH substantial financial flexibility and limits the burden of interest or refinancing. This conservative funding structure can help the company withstand volatility in portfolio results while preserving capacity to manage and develop healthcare holdings.
Read all positive factors
MPH Health Care AG (93M1) vs. iShares MSCI Germany ETF (EWG)
Market Cap
€116.88M
Dividend Yield18.32%
Average Volume (3M)2.03K
Price to Earnings (P/E)1.1
Beta (1Y)0.60
Revenue Growth-62.35%
EPS GrowthN/A
CountryDE
Employees2
SectorFinancial
Sector Strength70
IndustryAsset Management
Share Statistics
EPS (TTM)25.01
Shares Outstanding4,281,384
10 Day Avg. Volume1,009
30 Day Avg. Volume2,027
Financial Highlights & Ratios
PEG Ratio-0.38
Price to Book (P/B)0.39
Price to Sales (P/S)0.26
P/FCF Ratio765.62
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)8.7
Revenue Forecast (FY)€41.20M
MPH Health Care AG Business Overview & Revenue Model
Company Description
MPH Health Care AG is a German-based investment firm with a primary focus on the healthcare sector. The company's portfolio includes the production and distribution of medicinal products designed to treat serious illnesses like cancer, HIV, and va...
How the Company Makes Money
MPH Health Care AG primarily makes money through its role as a holding company by generating returns from its equity investments in portfolio companies. Key revenue and earnings drivers typically include (i) dividends and other distributions recei...
MPH Health Care AG Financial Statement Overview
Summary
Income Statement
56
Neutral
Balance Sheet
84
Very Positive
Cash Flow
34
Negative
| Breakdown | TTM | Mar 2026 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 358.93M | 364.30M | 6.11M | 7.24M | 6.85M | 4.36M |
| Gross Profit | 358.90M | 364.30M | 6.11M | 125.94M | 6.80M | 4.01M |
| EBITDA | 112.79M | 34.10M | 33.32M | 30.36M | 29.68M | -9.05M |
| Net Income | 107.05M | 29.30M | 32.04M | 29.54M | 29.11M | -8.96M |
Balance Sheet | ||||||
| Total Assets | 266.68M | 258.09M | 291.06M | 266.35M | 236.99M | 198.00M |
| Cash, Cash Equivalents and Short-Term Investments | 2.82M | 1.37M | 1.20M | 5.10M | 3.82M | 4.44M |
| Total Debt | 15.37M | 11.63M | 10.56M | 13.05M | 12.99M | 4.05M |
| Total Liabilities | 18.27M | 14.68M | 13.19M | 15.39M | 15.57M | 5.69M |
| Stockholders Equity | 248.41M | 243.41M | 277.87M | 250.97M | 221.42M | 192.31M |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 123.01K | 1.83M | -2.02M | -170.41K | -1.28M |
| Operating Cash Flow | 11.02M | 130.88K | 1.83M | -2.02M | -164.79K | -1.28M |
| Investing Cash Flow | -3.79M | -3.29M | 3.40M | 5.40M | -8.96M | 6.37M |
| Financing Cash Flow | -11.85M | -6.85M | -7.70M | 7.74M | -3.02M | -3.61M |
MPH Health Care AG Technical Analysis
Positive
25.10
Price Trends
25.14
Positive
24.08
Positive
20.94
Positive
Market Momentum
0.37
Positive
63.59
Neutral
25.80
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DE:93M1, the sentiment is Positive. The current price of 25.1 is below the 20-day moving average (MA) of 26.49, below the 50-day MA of 25.14, and above the 200-day MA of 20.94, indicating a bullish trend. The MACD of 0.37 indicates Positive momentum. The RSI at 63.59 is Neutral, neither overbought nor oversold. The STOCH value of 25.80 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for DE:93M1.
MPH Health Care AG Peers Comparison
UnderperformOutperform
Sector (68)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | €116.88M | 1.10 | 43.53% | 18.32% | -62.35% | ― | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
65 Neutral | €1.93B | 14.22 | 22.38% | 2.25% | 0.39% | 38.58% | |
50 Neutral | €21.27M | -1.88 | -127.78% | ― | ― | ― | |
41 Neutral | €524.10M | -2.66 | -26.46% | ― | -7.72% | -26.61% |
* Financial Sector Average
DE:93M1
MPH Health Care AG
27.30
12.47
84.04%
DE:B8FK
Biofrontera
3.50
0.83
31.09%
DE:EVT
Evotec
2.95
-3.39
-53.44%
DE:PA8
PAION AG
0.05
0.04
360.00%
DE:DMP
Dermapharm Holding SE
39.05
6.81
21.12%
DE:SBX
SynBiotic SE
1.06
-1.80
-62.94%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.